+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Multidrug resistant Gram-negative bacilli in lower respiratory tract infections



Multidrug resistant Gram-negative bacilli in lower respiratory tract infections



Iranian Journal of Microbiology 5(4): 323-327



Lower respiratory tract infections are among important causes of morbidity and mortality for all age groups. The emergence of multidrug resistant Gram-negative bacilli is an issue of increasing concern. A retrospective study including respiratory specimens (sputum and BAL) was conducted in our tertiary care centre. Samples were processed for microscopy, culture and susceptibility testing following standard methods. Multidrug resistant Gram-negative bacilli causing lower respiratory tract infections were studied for their causation of disease. The effect of appropriate treatment on clinical outcome was observed. A total of 472 Gram-negative pathogens were isolated from sputum and broncho-alveolar lavage fluid specimens during the study period. Among these Gram-negative pathogens 175 (37%) were found to be multidrug resistant. Klebsiella pneumoniae 85 (48.6%) and Acinetobacter spp. 59 (33.7%) were the predominant multidrug resistant Gram-negative bacilli isolated. Based on clinico-microbiological correlation, 138 (78.9%) multidrug resistant isolates were found to be pathogenic and the rest 37 (21.1%) were considered as colonizers. After initiating appropriate antibiotic therapy, clinical improvement was seen in 110 (79.7%) patients. In the patients who showed improvement, amikacin (34.3%) and cefoperazone-sulbactum (21.8%) were found to be the most effective drugs. A large majority of the isolated multidrug resistant Gram-negative bacilli were found to be pathogenic. Regular surveillance which directs appropriate empirical therapy; and good clinic-microbiological workup of each case of lower respiratory tract infection can reduce the morbidity and mortality associated with multidrug resistant organisms.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 058357179

Download citation: RISBibTeXText

PMID: 25848499


Related references

The management of infections with multidrug-resistant gram-negative bacilli in lower respiratory tract. Zhonghua Jie He He Hu Xi Za Zhi 40(8): 568-570, 2017

Multidrug-resistant Gram-negative bacilli causing urinary tract infections: clinical considerations. Journal of ChemoTherapy 23(3): 171-174, 2011

Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections. Journal of Antimicrobial ChemoTherapy 54(2): 566-569, 2004

Efficacy and safety of aztreonam vs. tobramycin for aerobic gram negative bacilli lower respiratory tract infections. American Journal of Medicine 78(2 PART A): 42-43, 1985

Comparison of aztreonam and tobramycin in the treatment of lower respiratory tract infections caused by gram-negative bacilli. Reviews of Infectious Diseases 7 Suppl 4: S666-S668, 1985

Efficacy and safety of aztreonam versus tobramycin for aerobic gram-negative bacilli lower respiratory tract infections. American Journal of Medicine 78(2a): 42-43, 1985

Distribution and drug-resistance of 345 strains gram-negative bacilli from hospitalized patients with lower respiratory tract infections diseases. Zhonghua Jie He He Hu Xi Za Zhi 21(10): 588-589, 2001

Colistin in the management of severe infections with multidrug resistant Gram-negative bacilli. Germs 4(1): 7-8, 2014

Drug resistance of imipenem-resistant Gram-negative bacilli in coal worker's pneumoconiosis chronic obstructive pulmonary disease patients with lower respiratory tract infection. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 31(9): 700-702, 2014

Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract. Annals of Internal Medicine 77(5): 701-706, 1972

Efficacy and safety of aztreonam-clindamycin versus tobramycin-clindamycin in the treatment of lower respiratory tract infections caused by aerobic gram-negative bacilli. Antimicrobial Agents and ChemoTherapy 27(2): 246-251, 1985

A comparative study of aztreonam clindamycin azc vs tobramycin clindamycin tc or amikacin mezlocillin am in lower respiratory tract infections caused by aerobic gram negative bacilli. Abstracts Of The Annual Meeting Of The American Society For Microbiology:, 1988

Invitro activity of imipenem-relebactam against gram-negative bacilli isolated from patients with lower respiratory tract infections in the United States in 2015 - Results from the SMART global surveillance program. Diagnostic Microbiology and Infectious Disease 88(2): 171-176, 2017

Clinicians' knowledge, attitudes, and practices regarding infections with multidrug-resistant gram-negative bacilli in intensive care units. Infection Control and Hospital Epidemiology 34(3): 274-283, 2013

Studies on the etiologic role of gram-negative bacilli in infections of the respiratory tract. Materia Medica Polona. Polish Journal of Medicine and Pharmacy 8(1): 65-74, 1976